Thromboangiitis obliterans (TAO) is a vascular disease that affects small and medium-sized arteries and veins of both upper and lower extremities. Distal…

Studies of family history (FH) have long been used to estimate the heritability of cardiovascular diseases (CVDs). Genome-wide association studies (GWAS)…

Oral anticoagulation with vitamin-K-antagonists has well known limitations and requires routine clinical monitoring of coagulation parameters. The new…

The aim of this symposium is to discuss the impact of poor treatment and poor inhaler technique on asthma outcomes. In addition, the symposium will…

Chronic obstructive pulmonary disease (COPD) is a major health issue worldwide, with disease burden, healthcare costs, and mortality rates all…

Inhalation therapy remains the cornerstone of treatment for bronchial diseases. Despite being pharmacologically efficacious, currently available inhaled…

Emphysema is a progressive, debilitating disease characterised by irreversible destruction of lung tissue. The gas trapping within the destroyed alveoli…

Chronic obstructive pulmonary disease (COPD) is often accompanied by other chronic diseases associated with systemic inflammation, such as chronic heart…

In the development of new antiallergic or antiasthmatic therapies, mouse models have helped to identify novel therapeutic agents. Before a medication is…

Asthma is a common disease among pregnant women. Uncontrolled asthma may increase the risk of maternal and foetal complications, thus optimal asthma…